FDA approves Sirturo for treating children with pulmonary multidrug-resistant TB
by Press Release from Outbreak News Today on (#54403)
The Janssen Pharmaceutical Companies of Johnson & Johnson announced this week that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO(R) (bedaquiline). SIRTURO(R) is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least [...]
The post FDA approves Sirturo for treating children with pulmonary multidrug-resistant TB appeared first on Outbreak News Today.